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Abstract
Background: Interaction of the iminium and alkanolamine forms of sanguinarine with bovine serum albumin (BSA) was
characterized by spectroscopic and calorimetric techniques.
Methodology/Principal Findings: Formation of strong complexes of BSA with both iminium and alkanolamine forms was
revealed from fluorescence quenching of sanguinarine. Binding parameters calculated from Stern-Volmer quenching
method revealed that the neutral alkanolamine had higher affinity to BSA compared to the charged iminium form. Specific
binding distances of 3.37 and 2.38 nm between Trp 212 (donor) and iminium and alkanolamine forms (acceptor),
respectively, were obtained from Forster resonance energy transfer studies. Competitive binding using the site markers
warfarin and ibuprofen, having definite binding sites, demonstrated that both forms of sanguinarine bind to site I
(subdomain IIA) on BSA. Sanguinarine binding alters protein conformation by reducing the a-helical organization and
increasing the coiled structure, indicating a small but definitive partial unfolding of the protein. Thermodynamic parameters
evaluated from isothermal titration calorimetry suggested that the binding was enthalpy driven for the iminium form but
favoured by negative enthalpy and strong favourable entropy contributions for the alkanolamine form, revealing the
involvement of different molecular forces in the complexation.
Conclusions/Significance: The results suggest that the neutral alkanolamine form binds to the protein more favourably
compared to the charged iminium, in stark contrast to the reported DNA binding preference of sanguinarine.
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Introduction
Alkaloids are secondary metabolites of plants especially
noteworthy for their remarkable biological activities and potential
medicinal use. Plant alkaloids are abundant in nature and have
relatively low toxicity to humans compared to other chemicals.
Sanguinarine (Figure 1), is a quaternary benzophenanthridine
alkaloid, found in many botanical species [1]. It is also a
component of argemone oil, responsible for ‘epidemic dropsy’
[2]. Sanguinarine exhibits multiple pharmacological effects,
including remarkable antimicrobial and anti-inflammatory prop-
erties [3,4], and is a potential lead compound in cancer therapy
inducing apoptosis in a variety of cancer cells through different
mechanisms [5–11]. Binding of sanguinarine to various DNA and
RNA structures and inhibition of the enzyme topoisomerase have
also been linked to its pronounced anticancer activity [12–16].
Structurally, sanguinarine can exist as the cationic iminium
(Figure 1A) and neutral alkanolamine (Figure 1B) forms with a
pKa of 7.4 [17]. The nucleic acid binding form has been the
charged iminium [18]. Although DNA and RNA binding of
sanguinarine has been studied extensively [12–20], binding to
proteins is yet to be investigated. Effectiveness and efficacy of
sanguinarine in therapeutic applications may be modified on the
basis of its interaction with serum albumins that may be critical for
understanding its toxicity and distribution in cells. Thus, to
understand and exploit the pharmaceutical benefit of sanguinarine
and to provide the molecular basis of drug action, its interaction
with protein must be understood.
Serum albumins, the most multifunctional transport proteins
and a major constituent of blood plasma, have many physiological
functions and facilitate the transportation and disposition of
several endogeneous and exogeneous compounds including
proteins and fatty acids to specific targets [21–23]. Bovine serum
albumin (BSA) is a globular heart-shaped protein, a 583 amino
acid residue monomer of 66.4 kDa composed of three structurally
similar domains (I, II and III), each containing two subdomains (A
and B) stabilized by 17 pairs of disulfide bridges [23,24]. BSA
considerably contributes to colloid osmotic blood pressure and
participates in the transport and distribution of many metabolites.
Ligand sequestration and transport by BSA impact many functions
like metabolism, membrane penetration, half life and other
pharmacokinetic properties. BSA has an excellent structural
homology of about 80% and repeating pattern of disulphide
bonds with human serum albumin. Many studies have revealed
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18333that targeted delivery of ligands by BSA is effected through
discrete binding sites in the hydrophobic cavities located in
subdomains IIA and IIIA in the three structurally similar a-helical
domains of the protein [25,26]. A number of studies on the
interaction of small molecules and drugs to BSA have been
recently reported [27–34] and elucidation of the molecular aspects
of the binding continues to be of great importance from the
standpoint of understanding protein structure-function on the one
hand and designing drug therapy and design on the other.
Here, we present a detailed study on the binding of
sanguinarine iminium and alkanolamine forms to bovine serum
albumin from a variety of biophysical experiments.
Results and Discussion
Absorption spectral study of the interaction
Sanguinarine iminium and alkanolamine forms have charac-
teristic absorption spectra in the range 300–550 nm that could be
monitored to understand the binding to BSA. There are two peaks
in this region for SI, a sharp one with maximum around 327 nm
and a broad one with maximum around 470 nm. For SA, there is
only one peak with maximum around 327 nm (see Figure 2B,
curve 1). Results of absorption spectral titration of constant
concentrations of SI form (11.06 mM) and SA form (10.94 mM)
with increasing concentration of BSA are presented in Figures 2A
& 2B. Binding resulted in quenching of the peak intensities with
saturation observed at D/Ps (drug/protein molar ratio) of 18 and
3.5, respectively, for SI and SA. The spectral data were analyzed
by Benesi-Hildebrand plot (inset of Figure 2A & 2B) to determine
the equilibrium constant using the equation,
1
DA
~
1
DAmax
z
1
KBG DAmax ðÞ
|
1
M ½ 
ð1Þ
The binding constants evaluated yielded KBH values of
1.6610
4 M
21 for the SI form and 3.46610
4 M
21 for the SA
form. These results suggest a twofold higher affinity of SA to BSA
over that of SI.
Fluorescence spectral study
To understand the effect of sanguinarine complexation on the
protein, the fluorescence of the tryptophan moiety of the protein
was monitored by exciting at 295 nm. BSA contains two
tryptophan (Trp) residues that possess intrinsic fluorescence
[35,36]. Trp 134 in the first domain is located on the surface in
the hydrophilic region of the protein while Trp 212 in the second
domain is located within a hydrophobic binding pocket [35]. It has
been reported that Trp residues inside the proteins are
characterized by a shorter wavelength emission maximum around
340 nm while those on or near the surface of a protein are
characterized a longer wavelength emission maximum [37]. Thus,
the fluorescence emission of BSA with maximum around 345 nm
when excited at 295 nm comes from the Trp residue at 212.
Binding of both SI and SA forms leads to decrease in the
fluorescence intensity with slight red shift, which may be due to a
variety of interactions like excited state reactions, molecular
rearrangements, energy transfer, ground state complexation and
collision quenching [38]. The fluorescence quenching data is
presented in Figures 3A & 3B. At wavelengths beyond 350 nm,
both SI and SA forms have strong emission maxima (vide infra) and
hence these regions are not presented. Saturation was achieved in
both cases. The occurrence of isoactinic points at 379 nm for SI
Figure 1. Chemical structure of sanguinarine. (A) iminium form (B) alkanolamine form.
doi:10.1371/journal.pone.0018333.g001
Figure 2. Representative absorption spectra of sanguinarine in
presence of BSA. (A) SI (11.06 mM) treated with 0, 22.12, 44.24, 66.36,
88.48, 110.6, 132.72, 154.84 mM (curves 1–8) of BSA and (B) SA
(10.94 mM) treated with 0, 5.5, 11, 16.5, 22, 27.5, 33, 38.5 mM (curves
1–8) of BSA. Inset: Respective Benesi-Hildebrand plots for binding.
doi:10.1371/journal.pone.0018333.g002
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forms of sanguinarine in equilibrium. The quenching data was
quantified by Stern-Volmer equation
F0
F
~1zKqt0½Q ~1zKSV½Q ð 2Þ
where Fo and F are the fluorescence intensities in the absence and
in the presence of the quencher, respectively. Kq is the quenching
rate constant. Ksv is the dynamic quenching rate constant, to is the
average lifetime of the protein without the quencher, which is of
the order of 10
28 s [39], and [Q] is the concentration of the
quencher. Dynamic quenching refers to a process where the
fluorophore and the quencher come into contact during the
lifetime of the excited state. Static quenching, on the other hand,
refers to fluorophore-quencher complex formation inthe ground
state. The plot of Fo/F versus [Q] was linear (not shown), which is
indicative of one type of quenching. The values of Ksv derived from
these plots were 7.58610
4 L. mol
21 and 3.65610
5 L. mol
21 for
the binding of SI and SA forms at 25uC (Table 1). Kq calculated
from the ratio of Ksv and to showed value of 7.58610
12 and
3.65610
13 L mol
21 s
21, respectively, for SI and SA. For dynamic
quenching, the maximum value of the scattering collision
quenching constant Kdiff is 2.0610
10 L mol
21 s
21 [40]. Since
the value of the biomolecular quenching is higher, it can be
assumed that the complex formation between the quencher and
the protein is by a static mechanism. The static quenching
mechanism was further confirmed from the temperature depen-
dence of the quenching; Ksv values decrease with increasing
temperature for static quenching while the reverse is observed for
dynamic quenching [38]. The fluorescence data were analyzed at
three different temperatures, viz. 15, 25 and 35uC. The Ksv values
Figure 3. The fluorescence spectra of (a) SI (1 mM) and (b) SA (1 mM) treated with BSA. In panel (A) curves (1–7) denote 0, 1, 2, 4, 6, 8 and
12 mM of BSA, and panel (B) curves (1–11) denote 0, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 2.0 and 2.8 mM of BSA, respectively. Fluorescence spectra of BSA
(1 mM) treated with different concentrations of (C) SI and (D) SA. In panel (C) curves (1–7) denote 0, 4, 6, 10, 16, 24, and 32 mM of SI and panel (D)
curves (1–7) denote 0, 0.3, 0.6, 0.9, 1.2, 1.5, 1.8 mM of SA, respectively.
doi:10.1371/journal.pone.0018333.g003
Table 1. Binding constants of sanguinarine iminium and
alkanolamine forms to BSA derived from the Stern-Volmer
method at different temperature.
Sanguinarine Temperature (K) Ksv /1 0
24 L. mol
21
Iminium 288 8.74
298 7.58
308 6.17
Alkanolamine 288 51.7
298 36.5
308 25.0
All the data presented are average of four determinations. The experiments
with iminium were performed in citrate-phosphate buffer of pH 6.4 and that
with alkanolamine form were performed in carbonate-bicarbonate buffer of
pH 9.2.
doi:10.1371/journal.pone.0018333.t001
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Volmer quenching constant Ksv and the quenching rate constant
Kq values (not shown) decreased with increasing temperature,
suggesting that the quenching mechanism was due to complex
formation rather than dynamic collision. In other words,
quenching of the fluorescence of BSA by both SI and SA forms
is due to specific complex formation; dynamic collision effects, if
any, shall be negligible.
The formation of specific sanguinarine-BSA complex was
further confirmed by monitoring the fluorescence changes of
sanguinarine upon binding to the protein. The SI and SA forms
have emission maxima at 564 and 420 nm, respectively, when
excited at 475 and 327 nm [41]. On titrating with BSA, the
fluorescence intensities of both forms quenched and attained
saturation (see Figure 3 C & 3D). The binding has been quantified
in terms of Stern-Volmer quenching plots. The Ksv values obtained
from this experiment for iminium and alkanolamine binding to
BSA were 7.2610
4 and 3.5610
5 L. mol
21, respectively. These
values are in close agreement with the Ksv values obtained from the
fluorescence quenching of the protein by sanguinarine (vide supra).
We examined the absorption spectra of the fluorophores in an
additional experiment to confirm the static quenching mechanism.
Since dynamic quenching affects only the excited states of the
fluorophores, changes in the absorption spectra are not expected
[38]. The difference absorption spectrum of sanguinarine and
BSA in the complex state was recorded. The absorption spectra of
BSA in presence of SI and SA forms are presented in Figure S1.
Two absorption bands were observed at 278 nm and 328 nm.
Sanguinarine iminium has absorption peaks in the same place as
BSA (cf. Figure S1). The change in the absorbance at 278 nm is
indicative of the influence of sanguinarine on the BSA spectrum
rather than a simple spectral overlap.
Energy Transfer from BSA to Sanguinarine and
Calculation of Binding Distance
The overlap (shaded) of the absorbance spectra of SI and SA
forms with the fluorescence emission spectrum of BSA is shown in
Figure 4A & 4B. The efficiency of energy transfer between
sanguinarine and the Trp 212 residue of BSA can be used to
evaluate the distance between them by Forster Resonance Energy
transfer (FRET). Energy transfer could occur through direct
electrodynamic interaction between the primarily excited mole-
cules and its neighbors [42] that may happen when the donor can
produce fluorescence light, when there is overlap between the
fluorescence emission spectrum of the donor and the absorbance
spectrum of the acceptor or when the distance between the donor
and the acceptor is ,8 nm [43]. By using the equation,
E~1-
F
F0
~
R6
0
R6
0zr6 ð3Þ
where E is the efficiency of energy transfer, F and Fo are the
fluorescence intensities in presence and absence of sanguinarine,
and, Ro is the critical distance when the efficiency of transfer is
50%, Ro can be calculated using the equation,
R6
0~8:79|10-25K2n-4QJ ð4Þ
where K
2 is the spatial factor of orientation, n is the refractive
index of the medium, and Q is the fluorescence quantum yield of
the donor. J is the overlap integral of the fluorescence emission
spectrum for the donor and the absorption spectrum of the
acceptor (Figure 4), which may be calculated from the equation,
J~
Ð ?
0 F l ðÞ el ðÞ l
4dl
Ð ?
0 F l ðÞ dl
ð5Þ
where F(l) is the fluorescence intensity of the donor at wavelength l
and e(l) is the molar absorption coefficient of the acceptor at
wavelength l. It was reported earlier [44] that for BSA n=1.36 and
p=0.15. Accordingly from the above equation J=2.131610
214 cm
3.
L. mol
21, E=0.27, Ro=2.85 nm, and the binding distance
r=3.37 nm for sanguinarine iminium, and J=1.286610
214 cm
3.L .
Figure 4. Spectral overlap (shaded portion) of sanguinarine absorption spectrum and BSA fluorescence spectrum at 256C. In panel
(A) and (B) curve 1 represent absorption spectra of iminium and alkanolamine form and curve 2 the fluorescence spectra of BSA. The ratio of the
concentration of [BSA]:[sanguinarine])=1:1. The excitation of BSA was done at 295 nm.
doi:10.1371/journal.pone.0018333.g004
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21,E = 0 . 6 4 ,R o=2.625 nm, and the binding distance
r=2.383 nm for the alkanolamine forms. So the distance between
Trp residue at position 212 of BSA and bound sanguinarine, both SI
and SA forms, is far lower than the 7 nm value and 0.5Ro,r,1.5Ro
indicating high probability of energy transfer [43] from BSA to
sanguinarine, in accordance with the static quenching mechanism.
This result indicated the obeying of the conditions of Forster energy
transfer theory for the binding, suggesting the location of both the
forms of bound sanguinarine to be in domain II of BSA where the Trp
212 is located.
Site selective binding of sanguinarine
Site marker fluorescence probes warfarin and ibuprofen were
used for monitoring site I and site II, respectively, of bovine serum
albumin. Warfarin, an anticoagulant, explicitly binds to site I in
the subdomain IIA while ibuprofen, a non steroidal anti-
inflammatory agent, primarily binds to site II located in the
subdomain IIIA [45–47]. Competitive binding experiments were
carried out with BSA-warfarin and ibuprofen complexes in
presence of SI and SA forms and the results are presented in
Figure 5A & 5B. The emission maximum of BSA shifts from 341
to 344 nm on complexation with warfarin for both the
sanguinarine forms. Addition of SI and SA forms quenched the
fluorescence intensity of BSA. Figures 5 C & 5D present the
comparative competitive binding pattern of ibuprofen-BSA
complex with sanguinarine. In contrast to warfarin, the fluores-
cence intensity of ibuprofen-BSA complex was the same as that of
free BSA and the binding of sanguinarine iminium and
alkanolamine forms induced quenching as in the absence of
ibuprofen. This indicated that sanguinarine binding was affected
very little, if at all, in presence of ibuprofen. Thus, both SI and SA
forms bind to site I in the subdomain IIA of BSA. In combination
with the fluorescence quenching results it can be elicited that Trp
212 is near or within the binding site of sanguinarine. Several
small molecules were found to bind to this location in BSA [48–53]
and this site appears to be favourable for small molecules. To
evaluate quantitatively the binding of sanguinarine in presence of
these site markers, the binding constants in their presence were
evaluated by modified Stern-Volmer equation
F0
DF
~
1
faKa
1
Q ½ 
z
1
fa
ð6Þ
where DF is the difference in fluorescence in the absence and
presence of the quencher at concentration [Q], f a is the fraction
of accessible fluorescence, and Ka is the effective quenching
constant for the accessible fluorophores, which is similar to the
binding constant for the quencher-acceptor systems. The depen-
dence of F0/DF on [Q]
21) is linear and the slope is ( f aKa)
21.
Figure 6A & 6B shows the modified Stern-Volmer plots of BSA-
Figure 5. Effect of site marker on the sanguinarine-BSA complex (T=298 K, lex=295 nm). C (warfarin)=C (BSA)=5 mM with SI (panel A)
and SA (panel B), respectively. C (ibuprofen)=C (BSA)=5 mM with SI form (panel C) and SA (panel D), respectively. In panel (A) curves (1–10)
correspond to 0, 0.5, 1.5, 2.5, 3.5, 4.5, 5.5, 6.5, 7.5 and 8.5 mM of SI and panel (C) curves (1–10) denote 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 mM of SA. Panel (B)
and (D) curves (1–8) denote 0 0.5, 1.0, 1.5, 2, 2.5, 3, 3.5 mM of SA.
doi:10.1371/journal.pone.0018333.g005
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The results reveal that the binding, which was only marginally
affected in presence of ibuprofen, was remarkably affected in
presence of warfarin confirming the affinity of sanguinarine to Trp
212 of site I (subdomain IIA) of BSA. The values of the quenching
constants for the complexes BSA-iminium and alkanolamine forms
in presence and absence of the site markers are presented in
Table 2.
Circular dichroism spectroscopy
Changes in the secondary and tertiary structure of the protein
can be inferred from far and near ultraviolet CD studies The far
uv CD spectrum of native BSA at both pH conditions showed two
minima at 209 and 222 nm (curve 1 in Figure 7 A & B) which is
typical of a-helical structure in accordance with the literature
reports [54,55]. The secondary protein conformation, determined
by the Jasco software, was found to contain ,56.0% a-helix,
,30% b-sheet (both parallel and antiparallel) and ,13% random
coil conformation at both pH conditions (Table 3). Within the pH
range 6.4–9.2 there is very little difference in the secondary and
tertiary structures of the protein as evidenced from CD studies.
Sanguinarine is not CD active. Upon titrating with increasing
concentrations of sanguinarine iminium and alkanolamine forms,
the CD spectrum of BSA decreased in intensity, indicating partial
unfolding of the helical structure. There were significant
differences in the extent of decrease in CD intensity by iminium
and alkanolamine forms. At saturation corresponding to 35 and
22 mmols of iminium and alkanolamine forms, there was a
reduction of a-helical structures to the extent of 16.4% and 18.3%
(Table 3). Thus, the unfolding was slightly more with the
alkanolamine form and at a much lower input ratio compared
to the iminium form. Thus binding of both forms of sanguinarine
induced secondary structural changes in BSA.
The near UV CD spectrum of BSA showed two minima around
262 and 290 nm, characteristic of the disulphide and aromatic
chromophores [56,57], and reflected the tertiary structural
organization of the protein. The ellipticity of the bands enhanced
(Figure 7C) on binding of sanguinarine iminium form, while with
the alkanolamine form they decreased slightly (Figure 7D).
Although the differential behavior of iminium and alkanolamine
forms on the near UV CD spectrum of the protein is not clear, the
changes clearly indicate the occurrence of tertiary structural
alteration leading to an unfolding of the native conformation. The
tertiary structural perturbation of BSA was observed to be
different with the cationic iminium compared to the neutral
alkanolamine form.
On binding to the protein, both iminium and alkanolamine
forms of sanguinarine, which are hitherto CD inactive acquired
induced circular dichroism manifested by a negative band around
340 nm band (Figure 7E & 7F). The change in the induced CD on
progression of the binding was similar but more pronounced with
alkanolamine form compared to the iminium. Thus, the strong
asymmetric environment of the protein induces optical activity in
the bound sanguinarine molecules, indicative of the strong and
similar bound environment of both forms of the alkaloid on the
protein.
Calorimetric characterization of sanguinarine-BSA
interaction
The interaction of the two forms of sanguinarine with BSA was
investigated from ITC studies. ITC measurements provide
detailed information [58] on thermodynamic quantities like
enthalpy of binding (DH), the entropy contribution to the binding
(TDS) and also the affinity and stoichiometry that can be
correlated to the results of other experiments. Figure 8A & 8B
(upper panels) shows representative calorimetric profiles of the
Figure 6. Modified Stern-Volmer plots of SI and SA of site
marker competitive experiments. Respective modified Stern-
Volmer plots of SI (panel A) and SA (panel B), blank (m), in presence
of warfarin (N) and in presence of ibuprofen (&).
doi:10.1371/journal.pone.0018333.g006
Table 2. Variation in the binding constant of sanguinarine
iminium and alkanolamine forms to BSA in presence of site
markers ibuprofen and warfarin derived by the modified
Stern-Volmer method at 25uC.
Sanguinarine Site marker Ka /10
24 L. mol
21
Iminium Blank 9.75
Ibuprofen 8.71
Warfarin 6.25
Alkanolamine Blank 28.0
Ibuprofen 24.8
Warfarin 13.9
The values are averages of four experiments. Experiments with iminium and
alkanolamine forms were conducted in citrate-phosphate buffer, pH 6.4, and
carbonate-bicarbonate buffer, pH 9.2, respectively.
doi:10.1371/journal.pone.0018333.t002
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The binding is exothermic in both the cases. The heat liberated in
each injection was corrected for the heat of dilution that was
determined in a separate but identical experiment injecting
sanguinarine into buffer alone. The resulting values were plotted
against the molar ratio of sanguinarine/BSA and fitted to a one-
site model by nonlinear least square method (curves in the lower
panel). The equilibrium constant (Kb), binding stoichiometry (N),
enthalpy change (DH), entropy contribution (TDS) and the free
energy change obtained from the calorimetric data are summa-
rized in Table 4. The binding constants of sanguinarine iminium
and alkanolamine forms to BSA are revealed to be 7.94610
4 M
21
and 3.78610
5 M
21, respectively. These values are fairly close to
the binding affinity values obtained from fluorescence titration
Figure 7. Intrinsic circular dichroic (CD far UV) spectral changes of BSA (1 mM) on interaction with SI (panel a) and SA (panel b). In
panel (A) curves 1–5 denote 0, 10, 15, 25 and 35 mM of SI and panel (B) curves 1–5 denote 0, 4, 8, 12 and 22 mM of SA. Near UV CD spectral changes of
BSA (2 mM) on interaction with SI (panel C) and SA (panel D). In panel (C) curves (1–4) denote 0, 10, 20, and 30 mM of SI and in panel (D) curves (1–4)
denote 0, 20, 40, and 60 mM of SA. Induced CD spectra of SI (50 mM) (panel E) and SA (50 mM) (panel F) on interaction with BSA. Curves (1–5) in panel
e denote 500, 400, 300, 200 and 100 mM and curves (1–5) in panel F denote 500, 400, 300, 200, and 100 mM of BSA, respectively.
doi:10.1371/journal.pone.0018333.g007
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(0.197) was smaller compared to that for the iminium (0.298). The
Gibbs energy change for the binding of the alkanolamine form was
higher than that of the iminium by about 1.3 kcal/mol. The
energetics of the interaction was also significantly different in the
two cases. The binding of the iminium was clearly enthalpy driven
(DH=26.148 kcal/mol) with a small entropy contribution
(TDS=0.320 kcal/mol), while that of the alkanolamine form was
driven by enthalpy changes (22.557 kcal/mol) and a strong
entropic component (TDS=5.125 kcal/mol) that was favorable to
the binding. The large value of enthalpy change for SI compared
to SA is indicative of a stronger electrostatic interaction of the
former with BSA and is due to the charge on the nitrogen atom.
Temperature dependent calorimetry results
To obtain insight into the forces driving the interaction between
sanguinarine and BSA, complex formation was examined as a
function of temperature (15–35uC). The binding isotherms
observed at different temperatures were sigmoidal (not shown).
Overall, as the temperature was increased, the binding enthalpies
were negative with their magnitudes increasing. The negative
enthalpy of binding at all temperatures indicated favorable
exothermic binding interaction between sanguinarine and the
protein. In case of SI, the entropy contribution became more and
more unfavorable with increasing temperature. Although the
entropy contribution decreased with increasing temperature in the
case of SA, it remained favorable for the binding even at 35uC.
This suggests that the binding of the iminium was driven by both
enthalpy and entropy at lower temperature, but the enthalpy of
binding becomes the dominant force at higher temperatures. With
SA on the other hand, the binding that was entropy dominated at
lower temperatures became enthalpy dominated at higher
Table 3. Variation of the secondary structure of BSA in
presence of different concentrations of sanguinarine iminium
and alkanolamine forms at 25uC.
Sanguinarine D/P a-Helix(%) b-Sheet(%) Random coil(%)
Iminium 0 56.8 30.1 13.1
10 55.9 30.7 13.4
15 54.0 31.5 14.5
25 47.5 34.7 17.8
35 40.4 37.2 22.4
Alkanolamine 0 55.6 31.1 13.3
4 53.4 34.0 12.6
8 50.0 36.8 13.2
12 46.1 37.4 16.5
22 37.3 42.4 20.3
Based on the Figure 7A & B the data were analyzed by the Jasco software for
secondary structure estimation. The experiments with iminium and alkanolamine
forms were performed in citrate-phosphate buffer of pH 6.4 and carbonate-
bicarbonate buffer of pH 9.2, respectively. D/P refers to drug/protein molar ratio.
doi:10.1371/journal.pone.0018333.t003
Figure 8. ITC profiles for the binding of sanguinarine to BSA. The top panels (A) and (B) present raw results for the sequential injection of SI
(2.0 mM) and SA (1 mM) into BSA solution (0.2 and 0.1 mM) and dilution of sanguinarine into buffer (curves on the top offset for clarity). The lower
panels show the integrated heat results after correction of heat of dilution against the mole ratio of sanguinarine/BSA. The points (closed squares)
were fitted to a one-site model and the solid lines represent the best-fit results.
doi:10.1371/journal.pone.0018333.g008
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differences in the molecular forces that contribute and control the
binding of iminium and alkanolamine forms to BSA.
From the variation of the enthalpy with temperature, ITC data
provides information on the heat capacity changes of the binding
[59]. The observed enthalpy varied linearly with the experimental
temperature in the range 15–35uC for both iminium and
alkanolamine forms indicating that there is no measurable shift
in the preexisting equilibrium between the conformational states of
BSA in the temperature range studied. Strong enthalpy-entropy
compensation was however observed, making Gibbs energy (DG)
of binding nearly independent of temperature (Figure 9A & 9B).
To determine the change in heat capacity (DCp), namely the first
derivative of temperature dependence of enthalpy change, the
data were plotted as DH versus temperature (Figure 10 A & 10B)
to yield DCp values of 2287 and 2148 cal mol K
21, respectively,
for the binding of iminium and alkanolamine forms. The negative
value of DCp in both cases indicates that the binding is specific and
accompanied by burial of non polar surface area [60,61]. In
addition, the negative heat capacity also causes the shift from a
predominantly entropy contributed binding to an enthalpy
dominated one as the temperature rises. In case of iminium, the
entropic contribution to the binding process is zero at 26.47uC
while for alkanolamine it is zero at 57uC. These are the
temperatures at which the binding process becomes completely
driven by enthalpy. Again, from the linear fit of the binding
enthalpy versus temperature, the net enthalpic contribution for the
binding of SI and SA is ,0 kcal/mol at 3.57 and 7.24uC,
respectively, with the binding process completely driven by
entropy. Thus, between 3.57 and 26.47uC for SI and 7.24 and
57uC for SA, the complex formation was favored by both enthalpy
and entropy contributions to the Gibbs energy. The temperature
dependence of the binding constants for the formation of BSA-SI
complex showed linear behavior while the same for BSA-SA
complex showed non-linear behavior (not shown). The non-linear
behavior for the latter may indicate contributions from linkage
interactions or conformational changes during the binding
process. It is pertinent to note that a stronger conformational
change was observed for the binding of alkanolamine form by CD
studies (vide supra). Furthermore, electrostatic interactions are
known to contribute a positive term to the heat capacity changes
and this may be the reason for the lower value of DCp for the
charged species SI compared to the neutral species SA. A higher
negative DCp for SA may also indicate a larger contribution from
other binding coupled events than that from surface burial. This
may involve strong H-bonding by the OH at the C6 position of SA
to amino acids of BSA. Such an H-bonding has been shown to
occur in sanguinarine-reductase-SA interactions [62]. A detailed
analysis of the various contributions to DCp is beyond the scope of
this paper and is not attempted.
Table 4. Temperature dependent isothermal titration calorimetric data for the binding of iminium and alkanolamine forms of
sanguinarine to BSA.
Sanguinarine
T
(K) N
Kb /
10
4 M
21
DG/
kcal mol
21
DH/
kcal mol
21
TDS/
kcal mol
21
DCp /
cal mol K
Iminium 288 0.349 9.44 26.665 23.295 3.370 2287
298 0.298 7.94 26.468 26.148 0.320
308 0.272 5.08 26.638 29.048 22.410
Alkanolamine 288 0.182 70.7 27.701 21.193 6.508 2148
298 0.197 37.8 27.682 22.557 5.125
308 0.185 14.3 27.553 24.165 3.388
All the data in this table are derived from ITC experiments and are average of four determinations. Kb and DH values were determined from ITC profiles fitting to Origin 7
software. The values of DG and TDS were determined using the equations DG=2RTlnKb and TDS=DH2DG. All the ITC profiles were fit to a model of single binding site.
The experiments with iminium and alkanolamine forms were performed in citrate-phosphate buffer of pH 6.4 and carbonate-bicarbonate buffer of pH 9.2, respectively.
doi:10.1371/journal.pone.0018333.t004
Figure 9. Plots of variation of thermodynamic parameters. DG
(&) and DH (N) versus TDS for the binding of sanguinarine iminium (A)
and alkanolamine (B) forms with BSA.
doi:10.1371/journal.pone.0018333.g009
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A study on the interaction of bovine serum albumin with
cationic and neutral forms of the benzophenanthridine alkaloid
sanguinarine has been performed. Absorbance and fluorescence
quenching studies provide evidence for the formation of strong
complexes. The binding parameters calculated from Stern-Volmer
quenching method revealed that the affinity to BSA was higher for
the neutral alkanolamine form compared to the charged iminium
form. Specific distances of 3.37 and 2.38 nm, respectively,
between Trp 212 and sanguinarine iminium and alkanolamine
forms were obtained from FRET studies. Thus, the iminium form
is bound closer to the Trp compared to alkanolamine form.
Competitive binding using site markers demonstrated that the
binding of both iminium and alkanolamine forms was at site I
(subdomain II) of BSA. Sanguinarine binding altered the protein
conformation by partially unfolding the structure; this was again
more pronounced with the alkanolamine form. Hydrophobic
interaction and van der Waals contacts along with H-bonding by
the 2OH group may contribute to the stronger binding of SA to
BSA. The alkanolamine form is more hydrophobic compared to
iminium. Furthermore, the p electrons of the aromatic SA ring
system may contribute negative charges that can also contribute as
electrostatic interaction with the positive charged sites available in
the protein. Thermodynamic studies suggest that the binding was
enthalpy driven for SI but was favoured by both negative enthalpy
and strong favourable entropy contributions with SA form. The
predominant hydrophobicity effect is clearly evident from the
relatively large entropy contribution for the alkanolamine form.
Electrostatic interaction may be the dominant force in the
iminium binding. This notion got strengthened from the fact that
there is a large enthalpic component for the binding of iminium
suggestive of forces other than hydrophobic effect to contribute
significantly to the binding. This must essentially come from
electrostatic, van der Waals and H-bonding interactions. The
results of binding to serum protein presented here are interesting
in the light of the strong binding of the iminium form and the
complete absence of binding of the alkanolamine form with
nucleic acids.
Materials and Methods
Biochemicals
Bovine serum albumin (BSA), sanguinarine, warfarin, ibuprofen
and all buffer salts were products of Sigma-Aldrich (St. Louis, MO,
USA).
Preparation of stock solutions
The samples were prepared in 10 mM citrate-phosphate buffer
of pH 6.4 and 10 mM carbonate-bicarbonate buffer of pH 9.2.
Concentrations were determined by UV absorbance measure-
ments using molar extinction coefficients of 43,824 M
21 cm
21 at
280 nm for BSA, 3.07610
4 M
21 cm
21 at 327 nm for iminium
and 2.16610
4 M
21 cm
21 for alkanolamine form, respectively.
Experiments with iminium and alkanolamine forms were con-
ducted in citrate-phosphate buffer, pH 6.4, and carbonate-
bicarbonate buffer, pH 9.2, respectively.
Absorbance spectroscopy
Absorbance spectral measurements were performed on a Jasco
V660 double beam double monochromator spectrophotometer
(Jasco International Co., Ltd. Tokyo, Japan) in 1 cm path length
strain-free matched quartz cells. Temperature of the cell holder
was controlled by a Lab companion water bath.
Fluorescence spectroscopy
Steady state fluorescence spectra were measured on a Shimadzu
RF5301PC spectrofluorimeter (Shimadzu Corporation, Kyoto,
Japan) using excitation and emission band pass of 3 nm. For
measurement of intrinsic fluorescence of BSA in presence of
sanguinarine, the protein sample was excited at 295 nm, the
excitation maximum of tryptophan, and emission spectra scanned
from 300 to 400 nm. In presence of BSA, iminium and
alkanolamine forms were excited at 475 and 327 nm, respectively.
Temperature dependent fluorescence spectral studies were
conducted on a Hitachi F4010 unit (Hitachi Ltd., Tokyo, Japan)
equipped with a Eyela Uni cool water bath (Tokyo Rikakikai Co.,
Tokyo, Japan) for controlling the sample temperature. The
temperature was monitored by the electronic devise Sensortek,
model BAT-12 (Sensortek Inc., NJ, USA).
Circular dichroism (CD) spectroscopy
A Jasco J815 spectropolarimeter (Jasco International Co., Ltd.
Tokyo, Japan) equipped with a peltier cell holder and temperature
controller PFD425 L/15 was used for monitoring the conforma-
tional changes in the protein on alkaloid binding. The protein
concentration and path length of the cell used were 1.0 mM and
Figure 10. Plot of the thermodynamic binding parameters of
sanguinarine-BSA complexation against temperature. TDS (m-
m), DH (N-N) and DG (&-&) for iminium form (panel A) and
alkanolamine form (panel B).
doi:10.1371/journal.pone.0018333.g010
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respectively. The instrument parameters for CD measurements
were scanning speed of 50 nm/min., bandwidth of 1.0 nm, and
sensitivity of 100 milli degree. Four scans were averaged and
smoothed to improve signal-to-noise ratio. The molar ellipticity
values are expressed in terms of mean residue molar ellipticity [h],
in units of deg. cm
2 dmol
21 taking a value of 113 as mean residue
weight for BSA. Secondary structure analysis was performed by
the software supplied by Jasco.
Isothermal titration calorimetry
The energetics of the binding of sanguinarine to BSA was
studied by isothermal titration calorimetry (ITC) using a VP ITC
unit (MicroCal, Northamption, MA, USA). The calorimeter cell
had a volume of 1.423 mL. All solutions were degassed under
vacuum (140 mbar, 10 min) on the Microcal’s Thermovac unit to
eliminate air bubbles before loading. The instrument control,
titration and analysis were performed through dedicated Origin 7
software provided with the unit. The titration experiments were
carried out as follows. The calorimeter syringe was filled with a
concentrated solution of the alkaloid (2 mM for the iminium form
and 1 mM for the alkanolamine form). Successive injections of
10 mL of this solution into 0.2 mM and 0.1 mM solutions of BSA,
respectively, in the same buffer contained in the calorimeter cell
was effected from the rotating syringe that enabled constant
stirring of the solution. The data were corrected for the heat of
dilution of sanguinarine, which was determined in a separate set of
experiments under identical conditions.
Supporting Information
Figure S1 Difference spectrum of BSA and sanguinarine
iminium (A) and alkanolamine forms (B).
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